Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers

Maturitas. 2008 Jun 20;60(2):71-7. doi: 10.1016/j.maturitas.2008.03.004. Epub 2008 May 9.
No abstract available

MeSH terms

  • Breast Neoplasms / genetics*
  • Breast Neoplasms / prevention & control*
  • Contraceptives, Oral, Hormonal / adverse effects
  • Estrogen Replacement Therapy / adverse effects
  • Fallopian Tubes / surgery
  • Female
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / prevention & control
  • Ovariectomy

Substances

  • Contraceptives, Oral, Hormonal